These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 23087428)
1. 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans. Miller MS; Tsibane T; Krammer F; Hai R; Rahmat S; Basler CF; Palese P J Infect Dis; 2013 Jan; 207(1):98-105. PubMed ID: 23087428 [TBL] [Abstract][Full Text] [Related]
2. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine. Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607 [TBL] [Abstract][Full Text] [Related]
3. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. Nachbagauer R; Wohlbold TJ; Hirsh A; Hai R; Sjursen H; Palese P; Cox RJ; Krammer F J Virol; 2014 Nov; 88(22):13260-8. PubMed ID: 25210189 [TBL] [Abstract][Full Text] [Related]
4. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
5. Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model. Roubidoux EK; Carreño JM; McMahon M; Jiang K; van Bakel H; Wilson P; Krammer F mBio; 2021 Feb; 12(1):. PubMed ID: 33593972 [TBL] [Abstract][Full Text] [Related]
7. Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses. Carter DM; Darby CA; Lefoley BC; Crevar CJ; Alefantis T; Oomen R; Anderson SF; Strugnell T; Cortés-Garcia G; Vogel TU; Parrington M; Kleanthous H; Ross TM J Virol; 2016 May; 90(9):4720-4734. PubMed ID: 26912624 [TBL] [Abstract][Full Text] [Related]
8. B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination. Sangster MY; Baer J; Santiago FW; Fitzgerald T; Ilyushina NA; Sundararajan A; Henn AD; Krammer F; Yang H; Luke CJ; Zand MS; Wright PF; Treanor JJ; Topham DJ; Subbarao K Clin Vaccine Immunol; 2013 Jun; 20(6):867-76. PubMed ID: 23576673 [TBL] [Abstract][Full Text] [Related]
9. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model. Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA Front Immunol; 2019; 10():756. PubMed ID: 31105689 [TBL] [Abstract][Full Text] [Related]
10. Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model. Park JK; Xiao Y; Ramuta MD; Rosas LA; Fong S; Matthews AM; Freeman AD; Gouzoulis MA; Batchenkova NA; Yang X; Scherler K; Qi L; Reed S; Athota R; Czajkowski L; Han A; Morens DM; Walters KA; Memoli MJ; Kash JC; Taubenberger JK Nat Med; 2020 Aug; 26(8):1240-1246. PubMed ID: 32601336 [TBL] [Abstract][Full Text] [Related]
11. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies. Kirchenbaum GA; Carter DM; Ross TM J Virol; 2016 Jan; 90(2):1116-28. PubMed ID: 26559834 [TBL] [Abstract][Full Text] [Related]
12. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses. Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study. Henry C; Palm AE; Utset HA; Huang M; Ho IY; Zheng NY; Fitzgerald T; Neu KE; Chen YQ; Krammer F; Treanor JJ; Sant AJ; Topham DJ; Wilson PC J Virol; 2019 Nov; 93(21):. PubMed ID: 31434733 [TBL] [Abstract][Full Text] [Related]
14. Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans. Christensen SR; Toulmin SA; Griesman T; Lamerato LE; Petrie JG; Martin ET; Monto AS; Hensley SE J Virol; 2019 Apr; 93(8):. PubMed ID: 30700610 [TBL] [Abstract][Full Text] [Related]
15. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes. Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119 [TBL] [Abstract][Full Text] [Related]
16. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. Krammer F; Hai R; Yondola M; Tan GS; Leyva-Grado VH; Ryder AB; Miller MS; Rose JK; Palese P; García-Sastre A; Albrecht RA J Virol; 2014 Mar; 88(6):3432-42. PubMed ID: 24403585 [TBL] [Abstract][Full Text] [Related]
17. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones. He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655 [TBL] [Abstract][Full Text] [Related]